Approval · Notice of Compliance 17562 · 2015
RABAVERT: Notice of Compliance 17562
Issued December 16, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17562
- Date
- December 16, 2015
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RABAVERT | 02267667 | Marketed |
Medicinal ingredients
- RABIES VACCINE INACTIVATED (PURIFIED CHICK EMBRYO CELL CULTURE) 2.5 UNIT per DOSE